Disc Medicine Announces $100M Proposed Public Offering Of Common Stock And Pre-Funded Warrants
Disc Medicine, Inc. (NASDAQ:IRON) (Disc), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic